• 검색 결과가 없습니다.

Oral antiviral agents for treatment of chronic hepatitis B

N/A
N/A
Protected

Academic year: 2021

Share "Oral antiviral agents for treatment of chronic hepatitis B"

Copied!
8
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

table 1.  Comparison of recommendations of AASLD, KASL, EASL guideline, and the medical insurance policy of Korea’s National Health Insurance regarding  indications for CHB treatment without histologic evidence
table 2.  Approved therapeutic agents for chronic hepatitis B
table 3.  Rescue therapy for chronic hepatitis B patients with suboptimal response or resistance to antivi- antivi-ral agents in clinical practice

참조

관련 문서

Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Adult immu- nization schedule recommended

Hepatitis B surface antigen loss in antiviral-treated patients with HBeAg(+) chronic hepatitis B (CHB) infection: observations from antiviral-naïve patients

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind,

miR-302c was markedly downregulated during HSC activation and TGF-b treatment in HSCs, and that miR-302c suppressed E6AP expression via binding to 3’- UTR of E6AP mRNA,

https://quizlet.com/_8gkp6x?x=1qqt&i=2tig8t 첨부한 프린트 자ㅊ ㄹㅎ료를 미리 부모님들께보내주세요.. 온라인 수업에 아이들 이

Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Detection of hepatitis C virus RNA

Baseline characteristics of genotype 1b chronic hepatitis C patients who treated with daclatasvir and asunaprevir (n=231)... Characteristics of genotype 1b

Background : Janus tyrosine kinase 2 (JAK2) V617F mutation has been described in a high proportion of patients with Philadelphia